Cellular therapies and biotherapies are growing areas of medicine that are transforming patient care. AABB works with the cellular therapies community to drive policies that ensure patient access, advance research, increase the supply and safety biological products, and expand coverage for these transformative therapies.
AABB to Host Instagram Takeover During Cord Blood Awareness Month
July 02, 2024
CMS Releases State RFA for CGT Access Model
July 02, 2024
FDA Simplifies Reporting for CAR T-Cell Therapies with REMS Update
July 01, 2024